Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus — Stella

Home/Post-hemorrhagic Hydrocephalus (PHH)/

View on ClinicalTrials.gov

Recruiting

Back to Post-hemorrhagic Hydrocephalus (PHH) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

The University of Texas Health Science Center at Houston, Houston, Texas

Key details

Phase

Early testing

Sponsor

Eva Sevick

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~20 participants

Started

January 2025

Primary completion

January 2029

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.